FAIRFAX, Va. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") technology company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders, today announced the closing of its merger transaction with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD). The Company is scheduled to begin trading on The Nasdaq Capital Market ("Nasdaq") under the new ticker symbol ‘AIFF' on August 13, 2024. "Brain health is a critical area of medicine that has been hindered by a lack of technological advancements needed to improve the treatme

FAIRFAX, Va., Aug. 09, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (NASDAQ:WAVD) ("WaveDancer" or the "Company"), announced today that it intends to effect a reverse stock split of its common stock at a ratio of one (1) post-split share for every three (3) pre-split shares. The reverse stock split will become effective at 12:01 p.m., New York time, on Monday, August 12, 2024, and will begin trading on a split-adjusted basis when the market opens on Tuesday, August 13, 2024. The new CUSIP number for the common stock following the reverse stock split will be 317970101. Additionally, in connection with the Agreement and Plan of Merger, dated as of November 15, 2023, as amended, by and between W

FAIRFAX, Va. and TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company"), a pioneering artificial intelligence ("AI") driven company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the expansion of its leadership team with the appointment of Samer Kaba, M.D. as its Chief Medical Officer, as it nears the closing of its planned merger with WaveDancer, Inc. (NASDAQ:WAVD). "We are delighted to welcome Samer to our executive management team," said Jon Olsen, Chief Executive Officer of Firefly. "His proven track record in the neuroscience drug developme

FAIRFAX, Va. and TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly"), a pioneering artificial intelligence ("AI") company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the appointment of Brian M. Posner to its Board of Directors upon closing of its planned merger with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD). Firefly has entered into a definitive agreement and plan of merger (as amended, the "Merger Agreement") with WaveDancer, which has been approved by the stockholders of both companies and both companies are working towards meeting the final closing cond

FAIRFAX, Va. And TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly"), a pioneering artificial intelligence ("AI") company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the appointment of David Johnson as its Executive Chairman upon closing of its planned merger with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD). Firefly has entered into a definitive agreement and plan of merger (as amended, the "Merger Agreement") with WaveDancer, which has been approved by the stockholders of both companies and both companies are working towards meeting the final closing condit

FAIRFAX, Va. and TORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company"), a pioneering AI company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, announces that Healthcare Science and AI Industry leader, David DeCaprio ("DeCaprio"), has entered into an agreement to join the Company's Board of Directors upon completion of the anticipated merger with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD). This appointment is a key step towards Firefly's anticipated start of trading on the NASDAQ. DeCaprio has significant experience transitioning advanced technology from ac

FAIRFAX, Va., March 18, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD) and Firefly Neuroscience, Inc. ("Firefly") an AI-driven brain health company, each received the requisite stockholder approvals required to consummate the merger between both companies. The WaveDancer stockholder approval was obtained at a special meeting of its stockholders held on March 14, 2024. The Firefly approval was obtained through a written consent by the holders of a majority of the outstanding voting shares of Firefly. Approval of the proposals by the WaveDancer stockholders will enable WaveDancer to proceed with its merger with Firefly, a medical technology and AI company developing

Most stockholders can vote via proxyvote.com or by calling 1-800-690-6903. FAIRFAX, Va., March 11, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (NASDAQ:WAVD) encourages its stockholders to participate actively by casting their vote now for the upcoming meeting of stockholders on March 14, 2024. The Board of Directors emphasizes the importance of this stockholders' vote, specifically urging a positive vote FOR each proposal contained in the proxy, a copy of which can be found at https://ir.wavedancer.com/sec-filings/all-sec-filings#document-1092-0001437749-24-003424-2. The Company believes a vote FOR each proposal is important for several reasons: Consummation of th

The white paper is titled "Brain Network Analytics (BNA) in the Psychiatric Practice: Real-Life Data Analysis" The analysis involved a cohort of 2,253 patients receiving treatment at a prominent psychiatric and multispecialty clinic in the U.S. FAIRFAX, Va. and TORONTO, March 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly"), a pioneering AI company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the findings presented in a 2023 white paper "Brain Network Analytics (BNA) in the Psychiatric Practice: Real-Life Data Analysis" by Charlotte Baumeister, Ph.D., with analysis by

FAIRFAX, Va., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") Chief Executive Officer, Jon Olsen, issues letter to stockholders ahead of Firefly's proposed merger with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD) pursuant to that definitive merger agreement, entered into on November 15, 2023, as amended on January 12, 2024 (the "Merger Agreement"). The transactions contemplated by the Merger Agreement, and other proposals described therein, are subject to stockholder approval sought at a special meeting of the stockholders of WaveDancer to be held virtually on March 14, 2024, at 10:00 A.M. ET. Stockholders are encouraged to participate in the meeting online by vis